Hot Stocks
Tuesday, March 15, 2016
UPDATE 1-Valeant cuts 2016 revenue forecast
March 15 (Reuters) - Valeant Pharmaceuticals International Inc cut its revenue forecast for the year by about 12 percent, or $1.5 billion, citing slower growth in its U.S. dermatology,...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment